SEC EDGAR Filing Information

Form SB-2 -- Optional form for registration of securities to be sold to the public by small business issuers

Filing Date Changed: 2006-05-10
Documents: 4
SEC Accession No.
0000812796-06-000025
Filing date: 2006-05-10
Accepted: 2006-05-10 16:30:40

Table of submitted documents:

Seq Type Document Size Description
1 SB-2 sb2april2006pipe.htm 1208006 SB2 APRIL 2006 PIPE
2 EX-23.1 sweeney.htm 3619 23.1 SWEEENEY CONSENT
3 EX-5.1 edwardsangell.htm 18397 5.1 CONSENT & OPINION EDWARDS ANGELL
4 EX-2.1 enteronmergeragreements.htm 33741 2.1 ENTERON MERGER AGREEMENTS
0000812796-06-000025.txt 1265335 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SB-2 | Act: 33 | File No.: 333-133975 | Film No.: 06826594
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139
305-534-3383
 Mailing Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139